Financial News
Articles published by Atara Biotherapeutics, Inc.
![](https://mms.businesswire.com/media/20221202005234/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221123005075/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Participate at the Evercore ISI 5th Annual HealthCONx Conference
November 23, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221109005932/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Participate at the Stifel Healthcare Conference
November 09, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221108006038/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress
November 08, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221102006157/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221101005404/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
November 01, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20221025006149/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20221013006075/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20221006005752/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220928005787/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220830005945/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220808005646/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update
August 08, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220802005858/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220802006151/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
August 03, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220801005025/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
August 01, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220712006116/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220706005779/en/778671/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220701005460/en/778671/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220604005008/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220603005033/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220519005615/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220504006179/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220505006060/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220429005657/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220428005344/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
April 28, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220421006031/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220404005914/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220404006039/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220401005459/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220315006164/en/1390741/4/Atara-Bio1_logo_300x185-1.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.